Concurrent alcohol dependence among methadone-maintained cocaine abusers is associated with greater abstinence
- PMID: 21463068
- PMCID: PMC3072227
- DOI: 10.1037/a0022795
Concurrent alcohol dependence among methadone-maintained cocaine abusers is associated with greater abstinence
Abstract
Concurrent alcohol dependence (AD) among polysubstance abusers has been associated with negative consequences, although it may not necessarily lead to poor treatment outcomes. One of the most efficacious treatments for cocaine abuse is contingency management (CM), but little research has explored the impact of AD on abstinence outcomes, particularly among patients in methadone maintenance. Using data from three trials of CM for cocaine use, we compared baseline characteristics and posttreatment and follow-up cocaine outcomes between methadone-maintained, cocaine-dependent patients (N = 193) with and without concurrent AD, randomized to standard care (SC) with or without CM. Patients with and without concurrent AD had similar baseline characteristics, with the exception that AD patients reported more alcohol use. AD patients achieved longer durations of cocaine abstinence and were more likely to submit a cocaine-negative sample at follow-up than non-AD patients. Patients randomized to CM achieved better outcomes than those randomized to SC, but there was no interaction between treatment condition and AD status. These findings suggest that cocaine-using methadone patients with AD achieve greater cocaine abstinence than their non-AD counterparts and should not necessarily be viewed as more difficult to treat.
Figures


References
-
- Alterman AI, Kampman K, Boardman CR, Rutherford MJ, McKay JR, Maany I. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence. 1997;46:79–85. - PubMed
-
- Alterman AI, McKay JR, Mulvaney FD, Cnaan A, Cacciola JS, Tourian KA, et al. Baseline prediction of 7-month cocaine abstinence for cocaine dependency patients. Drug and Alcohol Dependence. 2000;59:215–221. - PubMed
-
- Bunney EB, Appel SB, Brodie MS. Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area. The Journal of Pharmacology and Experimental Therapeutics. 2001;297:696–703. - PubMed
-
- Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: Clinical and prognostic significance. Journal of Studies on Alcohol. 1993;54:199–208. - PubMed
-
- Chatham LR, Rowan-Szal GA, Joe GW, Brown BS, Simpson DD. Heavy drinking in a population of methadone-maintained clients. Journal of Studies on Alcohol. 1995;56:417–422. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA013444/DA/NIDA NIH HHS/United States
- P30-DA023918/DA/NIDA NIH HHS/United States
- T32-AA07290/AA/NIAAA NIH HHS/United States
- R01-DA024667/DA/NIDA NIH HHS/United States
- P50 DA009241/DA/NIDA NIH HHS/United States
- R01 DA021567/DA/NIDA NIH HHS/United States
- R01 DA024667/DA/NIDA NIH HHS/United States
- M01 RR006192/RR/NCRR NIH HHS/United States
- R01-DA021567/DA/NIDA NIH HHS/United States
- R01-DA022739/DA/NIDA NIH HHS/United States
- P60 AA003510/AA/NIAAA NIH HHS/United States
- R01-DA016855/DA/NIDA NIH HHS/United States
- R01-DA027615/DA/NIDA NIH HHS/United States
- R01-DA13444/DA/NIDA NIH HHS/United States
- R01 DA027615/DA/NIDA NIH HHS/United States
- R01-DA018883/DA/NIDA NIH HHS/United States
- R21-DA021836/DA/NIDA NIH HHS/United States
- R01 DA014618/DA/NIDA NIH HHS/United States
- R01 DA022739/DA/NIDA NIH HHS/United States
- M01-RR06192/RR/NCRR NIH HHS/United States
- T32 AA007290/AA/NIAAA NIH HHS/United States
- R01 DA018883/DA/NIDA NIH HHS/United States
- R01 DA016855/DA/NIDA NIH HHS/United States
- R21 DA021836/DA/NIDA NIH HHS/United States
- R01-DA14618/DA/NIDA NIH HHS/United States
- P60-AA03510/AA/NIAAA NIH HHS/United States
- P30 DA023918/DA/NIDA NIH HHS/United States
- P50-DA09241/DA/NIDA NIH HHS/United States